- Elixinol Wellness Ltd and BRITISH CANNABISโข have entered into an exclusive Trademark & Know-How License Agreement for the UK market, starting in December 2021
- BRITISH CANNABISโข will become the exclusive UK manufacturer and distributor of Elixinolโs dynamic range of CBD supplements and cosmetics
- Elixinol products will continue to trade in a key and competitive UK cannabinoid market, in tandem with the legacy of BRITISH CANNABISโข and its dedication to compliant, Novel Foods registered CBD products.
CBD Health Foods Ltd, trading as BRITISH CANNABISโข, is pleased to announce that it has entered into an exclusive Trademark & Know-How License Agreement (Agreement) with Elixinol Wellness Limited (Elixinol) (ASX:EXL; OTCQB:ELLXF), the wholly owned subsidiary of Elixinol Wellness (Corporate Services) Pty Ltd, to sell CBD products across the UK.
Given the complex and ongoing developments with the regulatory environment in the UK and given Elixinolโs strategic focus on driving profitability, Elixinol made the considered decision in 2021 to cease trading in the UK and EU markets and instead move to an indirect route to market by seeking a licensing partner in the UK.
The Elixinol and BRITISH CANNABISโข Agreement enables Elixinolโs strong brand to still be distributed in the UK, whilst handing over the cost and expertise for its UK operations.
The appointment of BRITISH CANNABISโข as the sole and exclusive Licensee of Elixinol-branded products in the UK, for a three-year term, marks a pivotal agreement in the course of the UK cannabinoid market. Both parties are in the early stages of market planning, which include renewed support of existing Elixinol sales channels, key retail customers and consumers. The shared aim is to improve revenues across the board, whilst building on the legacy set by Elixinolโs founders over 10 years ago, ensuring a continued execution of Elixinolโs global strategy.
Established in 2015, BRITISH CANNABISโข is the largest independently owned, producer, manufacturer and distributor of legal cannabis-derived products in the UK. It has a suite of successful branded flagship products, along with a range of white label brands Powered by BRITISH CANNABISโข. With a focus on innovation, quality, accuracy and compliance that has backed products from this UK cannabis industry original for over 6 years, this focus now looks set to support the dynamic range of wellness solutions at Elixinol.
We are delighted about the prospect of partnering with BRITISH CANNABISโข who are the most established manufacturer and distributor of branded and white label CBD products in the UK.
BRITISH CANNABISโขโ Canabidolโข brand is widely distributed in UK pharmacies, demonstrating the companyโs credentials and capabilities to build brands in sophisticated retail channels. BRITISH CANNABISโ manufacturing capability also allows us to manufacture Elixinol products in the UK and thus create a more efficient supply chain solution.
Through the partnership with BRITISH CANNABIS, UK consumers will now continue to be able to buy their favorite Elixinol products and we are very excited to see the brand continue following many years of building the brand.Oliver Horn | Elixinol Global CEO
BRITISH CANNABISโข CEO, Tom Whettem, commented
It is an honour to be asked to continue the legacy of Elixinol here in our home market. The prospect of a dynamic partnership between Australiaโs leading global CBD range and the UKโs premier manufacturer has excited both myself and our leadership team.
The ranges from the companies complement each other in several ways and continuing the legacy of Elixinol galvanizes us. With the security of our Novel Foods dossiers, the potential to take this reinforced portfolio to market makes for a very solid proposition for retailers and provides the CBD supplements consumer with great choices.Tom Whettem | BRITISH CANNABISโข CEO
This document was authorised to be given to the ASX by the Board of the Company. Investor relations please contact: Ron Dufficy | Global CFO ron.dufficy@elixinolglobal.com
About Elixinol
Elixinol Wellness Limited (ASX:EXL; OTCQB:ELLXF) is a global leader in the hemp industry, innovating, marketing and selling hemp derived nutraceutical, cosmetic and food products. The Companyโs simplified business model is focusing on:
- In the Americas, innovating, marketing and selling high quality Elixinol branded hemp derived nutraceutical and skincare products based in Colorado, USA
- In Europe and the UK, educating and selling high quality Elixinol branded and co-branded hemp derived nutraceutical and skincare products based in Utrecht, The Netherlands and London, UK
- In Australia, Hemp Foods Australia is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products
- Across the Rest of World, expanding distribution of Elixinol branded hemp derived products through reputable distributors as key markets open.
BRITISH CANNABISโข can be reached on +44 (0)203 965 2420 or via email at info@britishcannabis.org
BRITISH CANNABISโข - A UK CBD Industry Original
BRITISH CANNABISโข is the largest producer, manufacturer, and distributor of legal cannabis-derived products in the UK. They own and operate a unique extraction and purification facility in England and provide analytical testing, bulk extracts and white label products to the UK market leading brands.
With over a thousand CBD food supplement products, included across no less than 15 thorough applications to the Food Standards Agency, the makers of Canabidolโข,ย ACCESS CBDโข and many successful white label brands are set to bring cannabis-based wellness products to the people for years to come.